Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine

Biochemical and Biophysical Research Communications

Volumn 468, Issue 3, 2015, Pages 485-489

  Kim, Sang Soo ^a   Harford, Joe B ^b   Pirollo, Kathleen F ^a   Chang, Esther H ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b SynerGene Therapeutics Inc   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Cancer stem cells; Chemosensitization; Glioblastoma multiforme; Targeted nanomedicine; Therapeutic resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; CETUXIMAB; LIPOSOME; NANOPARTICLE; POLYMER; SGT 53; SINGLE WALLED NANOTUBE; TAMOXIFEN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; NANOCAPSULE;

ANGIOGENESIS; BLOOD BRAIN BARRIER; CANCER STEM CELL; CYTOPLASM; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; MACROMOLECULE; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; RADIOSENSITIZATION; REVIEW; STEREOTAXIC SURGERY; TARGET CELL; TRANSCYTOSIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN NEOPLASMS; CHEMISTRY; DIFFUSION; DRUG EFFECTS; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; DIFFUSION; GLIOBLASTOMA; HUMANS; NANOCAPSULES; NEOPLASTIC STEM CELLS;

EID: 84951570439     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.137     Document Type: Review

References (60)

1. D. Sehedic, A. Cikankowitz, F. Hindre, and et al. Nanomedicine to overcome radioresistance in glioblastoma stem-like cells and surviving clones Trends Pharmacol. Sci. 36 2015 236 252
2. C.H. Wang, S.H. Chiou, C.P. Chou, and et al. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody Nanomedicine 7 2011 69 79
3. L.C. Hou, A. Veeravagu, A.R. Hsu, and V.C. Tse Recurrent glioblastoma multiforme: a review of natural history and management options Neurosurg. Focus 20 2006 E5
4. G.F. Woodworth, G.P. Dunn, E.A. Nance, and et al. Emerging insights into barriers to effective brain tumor therapeutics Front. Oncol. 4 2014 126
5. M.C. Chamberlain Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas Expert Rev. Neurother. 10 2010 1537 1544
6. S.S. Kim, A. Rait, E. Kim, and et al. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme Nanomedicine 11 2015 301 311
7. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 8 2008 755 768
8. S.S. Kim, A. Rait, F. Rubab, and et al. The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells Mol. Ther. 22 2014 278 291
9. S. Bao, Q. Wu, R.E. McLendon, and et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
10. S.J. Sundar, J.K. Hsieh, S. Manjila, and et al. The role of cancer stem cells in glioblastoma, Neurosurg. Focus 37 2014 E6
11. K.B. Pointer, P.A. Clark, M. Zorniak, and et al. Glioblastoma cancer stem cells: biomarker and therapeutic advances Neurochem. Int. 71 2014 1 7
12. R. Esparza, T.D. Azad, A.H. Feroze, and et al. Glioblastoma stem cells and stem cell-targeting immunotherapies J. Neurooncol. 2015
13. Y.P. Ramirez, J.L. Weatherbee, R.T. Wheelhouse, and A.H. Ross Glioblastoma multiforme therapy and mechanisms of resistance Pharm. Basel 6 2013 1475 1506
14. S. Vinogradov, and X. Wei Cancer stem cells and drug resistance: the potential of nanomedicine Nanomedicine Lond. 7 2012 597 615
15. G. Liu, X. Yuan, Z. Zeng, and et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Mol. Cancer 5 2006 67
16. D.Y. Cho, S.Z. Lin, W.K. Yang, and et al. The role of cancer stem cells (CD133(+)) in malignant gliomas Cell Transpl. 20 2011 121 125
17. S. Bao, Q. Wu, S. Sathornsumetee, and et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res. 66 2006 7843 7848
18. M. Jhanwar-Uniyal, M. Labagnara, M. Friedman, and et al. Glioblastoma: molecular pathways, stem cells and therapeutic targets Cancers Basel 7 2015 538 555
19. M. Jackson, F. Hassiotou, and A. Nowak Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target Carcinogenesis 36 2015 177 185
20. D. Peer, J.M. Karp, S. Hong, and et al. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
21. K.K. Jain Advances in the field of nanooncology BMC Med. 8 2010 83
22. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664
23. S. Mallidi, K. Watanabe, D. Timerman, and et al. Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging Theranostics 5 2015 289 301
24. M.J. Alonso Nanomedicines for overcoming biological barriers Biomed. Pharmacother. 58 2004 168 172
25. S.S. Kim, H. Garg, A. Joshi, and N. Manjunath Strategies for targeted nonviral delivery of siRNAs in vivo Trends Mol. Med. 15 2009 491 500
26. F. Yuan, M. Dellian, D. Fukumura, and et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 55 1995 3752 3756
27. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
28. R.K. Jain Barriers to drug delivery in solid tumors Sci. Am. 271 1994 58 65
29. S. Bamrungsap, Z. Zhao, T. Chen, and et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system Nanomedicine Lond. 7 2012 1253 1271
30. C.T. Jordan Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 4 2009 203 205
31. L. Jin, K.J. Hope, Q. Zhai, and et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nat. Med. 12 2006 1167 1174
32. J. Lang, X. Lan, Y. Liu, and et al. Targeting cancer stem cells with an (131)I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts Nucl. Med. Biol. 42 2015 505 512
33. C. Naujokat Monoclonal antibodies against human cancer stem cells Immunotherapy 6 2014 290 308
34. P. Kumar, H. Wu, J.L. McBride, and et al. Transvascular delivery of small interfering RNA to the central nervous system Nature 448 2007 39 43
35. D.M. Long Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors J. Neurosurg. 32 1970 127 144
36. A. Bhowmik, R. Khan, and M.K. Ghosh Blood brain barrier: a challenge for effectual therapy of brain tumors Biomed. Res. Int. 2015 2015 320941
37. P.Y. Wen, and S. Kesari Malignant gliomas in adults N. Engl. J. Med. 359 2008 492 507
38. L. Juillerat-Jeanneret The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13 2008 1099 1106
39. S. Noell, D. Mayer, W.S. Strauss, and et al. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results Int. J. Oncol. 38 2011 1343 1348
40. M. Glas, B.H. Rath, M. Simon, and et al. Residual tumor cells are unique cellular targets in glioblastoma Ann. Neurol. 68 2010 264 269
41. N. McDannold, C.D. Arvanitis, N. Vykhodtseva, and M.S. Livingstone Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques Cancer Res. 72 2012 3652 3663
42. E. Allard, C. Passirani, and J.P. Benoit Convection-enhanced delivery of nanocarriers for the treatment of brain tumors Biomaterials 30 2009 2302 2318
43. E.C. de Lange, B.A. de Boer, and D.D. Breimer Microdialysis for pharmacokinetic analysis of drug transport to the brain Adv. Drug Deliv. Rev. 36 1999 211 227
44. M. Miyagami, T. Tsubokawa, M. Tazoe, and Y. Kagawa Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors Neurol. Med. Chir. Tokyo 30 1990 582 590
45. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81
46. P. Calvo, B. Gouritin, H. Chacun, and et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery Pharm. Res. 18 2001 1157 1166
47. R.L. Dean, D.F. Emerich, B.P. Hasler, and R.T. Bartus Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone Neuro Oncol. 1 1999 268 274
48. S.S. Kim, A. Rait, E. Kim, and et al. A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival ACS Nano 8 2014 5494 5514
49. T. Birngruber, R. Raml, W. Gladdines, and et al. Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx, (®)/Doxil(®)-a cerebral open flow microperfusion pilot study J. Pharm. Sci. 103 2014 1945 1948
50. R.J. Boado, J.Z. Lu, E.K. Hui, and et al. Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor Biotechnol. Bioeng. 110 2013 1456 1465
51. B.K. Hendricks, A.A. Cohen-Gadol, and J.C. Miller Novel delivery methods bypassing the blood-brain and blood-tumor barriers Neurosurg. Focus 38 2015 E10
52. Y. Li, H. He, X. Jia, and et al. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas Biomaterials 33 2012 3899 3908
53. Y.P. Yang, Y. Chien, G.Y. Chiou, and et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI Biomaterials 33 2012 1462 1476
54. D. Beier, J.B. Schulz, and C.P. Beier Chemoresistance of glioblastoma cancer stem cells-much more complex than expected Mol. Cancer 10 2011 128
55. A.D. Berezovsky, L.M. Poisson, D. Cherba, and et al. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation Neoplasia 16 2014 193-206, 206 e119-125
56. H.J. Jun, R.T. Bronson, and A. Charest Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma Stem Cells 32 2014 338 348
57. H.W. Lo EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance Curr. Mol. Pharmacol. 3 2010 37 52
58. M. Kaluzova, A. Bouras, R. Machaidze, and C.G. Hadjipanayis Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles Oncotarget 6 2015 8788 8806
59. T. Miyamoto, N. Tanaka, Y. Eishi, and T. Amagasa Transferrin receptor in oral tumors Int. J. Oral Maxillofac. Surg. 23 1994 430 433
60. X. Wang, X. Huang, Z. Yang, and et al. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells Curr. Pharm. Biotechnol. 15 2014 839 846